Financial & Corporate Governance
Investor Relations
G.D. Pharmaceuticals Limited has proposed offering its shares to the general public. This section will host our prospectus, financial statements, general meeting notices and IPO updates.
Public Ltd
Corporate Status
NPR 50Cr+
Paid-Up Capital
Birgunj
Manufacturing Hub
WHO-GMP
Audit Standard
Financial Disclosures & Reports
Statutory documents, quarterly statements, audit reports, and investor notices filed under SEBON and company registrar protocols.
Notice of Special General Meeting
31 May 2026
Prospectus
After SEBON approval
Audited financial statements
To be published
Annual General Meeting notices
To be published
Shareholder Registry
For queries concerning share certificates, transfer verifications, AGM schedule notifications, or change of address:
Share RegistrarG.D. Secretarial Desk / Nabil Investment
Email Deskinvestors@gd-pharmaceuticals.com
Headquarters Phone+977 (01) 441-2345
Had a side effect from one of our medicines?
Tell us. Every report helps us keep our products safe. In an emergency, see a doctor first.